Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease-Reference-Cited by-同舟云学术

Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease

Published:2021-07-16 Issue:3 Volume:90 Page:
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol

Author:

Heinzel Sebastian¹^ORCID,Aho Velma T. E.²³^ORCID,Suenkel Ulrike⁴,Thaler Anna‐Katharina⁴,Schulte Claudia⁴⁵,Deuschle Christian⁴⁵,Paulin Lars²,Hantunen Sari⁶,Brockmann Kathrin⁴⁵^ORCID,Eschweiler Gerhard W.⁷⁸,Maetzler Walter¹,Berg Daniela¹⁴,Auvinen Petri²,Scheperjans Filip³^ORCID

Affiliation:

1. Department of Neurology Christian‐Albrechts University Kiel Germany

2. Institute of Biotechnology University of Helsinki Helsinki Finland

3. Department of Neurology, Helsinki University Hospital and Department of Clinical Neurosciences (Neurology) University of Helsinki Helsinki Finland

4. Department of Neurodegeneration, Hertie Institute for Clinical Brain Research University of Tübingen Tübingen Germany

5. German Center for Neurodegenerative Diseases University of Tübingen Tübingen Germany

6. Institute of Public Health and Clinical Nutrition University of Eastern Finland Kuopio Finland

7. Department of Psychiatry and Psychotherapy, Geriatric Center Tübingen University Hospital Tübingen Germany

8. Geriatric Center, Tübingen University Hospital Tübingen Germany

Funder

Academy of Finland

German Center for Neurodegenerative Diseases

Finnish Medical Foundation

Janssen Pharmaceuticals

Teva Pharmaceutical Industries

Werner Reichardt Centre for Neuroscience

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26128

Reference50 articles.

1. Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients

2. Prediagnostic presentations of Parkinson's disease in primary care: a case-control study

3. Frequency of bowel movements and the future risk of Parkinson’s disease

4. Gut–brain axis and the spread of α‐synuclein pathology: Vagal highway or dead end?

5. Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiota-gut-liver-brain axis and hepatic encephalopathy;Microbiome Research Reports;2024-01-25

2. Relationship among Parkinson’s disease, constipation, microbes, and microbiological therapy;World Journal of Gastroenterology;2024-01-21

3. Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease;Neural Regeneration Research;2024-01-12

4. Relationships Between Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease: Indication from Gut Microbiota Alterations;Aging and disease;2024

5. Research Progress of Gut Microbiota on Parkinson’s Disease;Advances in Clinical Medicine;2024